[TIA: vitamin K antagonists versus antiplatelet drugs]

Dtsch Med Wochenschr. 2013 Apr;138(17):876. doi: 10.1055/s-0032-1329156. Epub 2013 Apr 16.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Dose-Response Relationship, Drug
  • Humans
  • International Normalized Ratio
  • Intracranial Embolism / blood
  • Intracranial Embolism / diagnosis
  • Intracranial Embolism / drug therapy*
  • Ischemic Attack, Transient / blood
  • Ischemic Attack, Transient / diagnosis
  • Ischemic Attack, Transient / drug therapy*
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Practice Guidelines as Topic
  • Risk
  • Secondary Prevention
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Vitamin K